CDK4 activity in mouse embryos expressing a single D-type cyclin

Maria A Ciemerych1, Qunyan Yu, Katarzyna Szczepanska

  • 1Department of Embryology, University of Warsaw, Warsaw, Poland. ciemerych@biol.uw.edu.pl

Insights

Cyclin D3 and D2 activate CDK4 similarly to wild-type embryos, but cyclin D1 does not. Cyclin D1-dependent CDK4 activity is not essential for mouse embryonic development.

Area of Science:

  • Cell Biology
  • Developmental Biology
  • Molecular Biology

Background:

  • D-type cyclins (D1, D2, D3) are key regulators of the cell cycle.
  • They associate with cyclin-dependent kinases (CDKs) like CDK4 and CDK6.
  • This complex phosphorylates the retinoblastoma protein (pRb), controlling cell cycle progression.

Purpose of the Study:

  • To investigate the distinct roles of individual D-type cyclins in CDK activation and pRb phosphorylation.
  • To determine if cyclin D1, D2, and D3 have interchangeable functions during mouse embryonic development.

Main Methods:

  • Generation of mouse embryos expressing single D-type cyclins (cyclin D1-only, D2-only, D3-only).
  • Assay of CDK4 activity in these mutant embryos.
  • Analysis of cyclin D1 mRNA expression patterns during embryogenesis.

Main Results:

  • CDK4 activity was comparable in wild-type, cyclin D3-only, and cyclin D2-only embryos.
  • No detectable CDK4 activity was observed in cyclin D1-only embryos, despite complex formation with CDK4.
  • Cyclin D1 mRNA expression is temporally regulated during mouse embryogenesis.

Conclusions:

  • Cyclin D1-dependent CDK4 activity is dispensable for normal mouse embryonic development.
  • The functions of D-type cyclins in CDK activation are not entirely redundant.
  • Temporal regulation of cyclin D1 expression may influence its role in development.

Related Concept Videos

Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...